Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G G Mather

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Biochemical Pharmacology|July 29, 1999
Cytotoxicity induced by the combination of valproic acid and tumor necrosis factor-alpha: implication for valproic acid-associated hepatotoxicity syndromeC P Yao, G G Mather, J R Stephens, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|May 1, 1991
Effects of subchronic exposure of rats to 2-methoxyethanol or 2-butoxyethanol: thymic atrophy and immunotoxicityJ H Exon, G G Mather, J L Bussiere, et al.
Reproductive Toxicology (Elmsford, N.Y.)|April 23, 1999
Effect of stiripentol dose on phenytoin-induced teratogenesis in a mouse modelR H Finnell, G D Bennett, G G Mather, et al.
Clinical Pharmacokinetics|October 7, 1997
Pharmacokinetic interactions with felbamate. In vitro-in vivo correlationP Glue, C R Banfield, J L Perhach, et al.
Chirality|February 26, 2000
Nefopam enantiomers: preclinical pharmacology/toxicology and pharmacokinetic characteristics in healthy subjects after intravenous administrationG G Mather, R Labroo, M E Le Guern, et al.
Journal of Clinical Pharmacology|March 20, 1998
Lack of effect of azelastine and ketoconazole coadministration on electrocardiographic parameters in healthy volunteersJ Morganroth, W H Lyness, J L Perhach, et al.
Clinical Pharmacology and Therapeutics|December 9, 1997
Influence of stiripentol on cytochrome P450-mediated metabolic pathways in humans: in vitro and in vivo comparison and calculation of in vivo inhibition constantsA Tran, E Rey, G Pons, et al.
Epilepsia|July 10, 2002
Topiramate and phenytoin pharmacokinetics during repetitive monotherapy and combination therapy to epileptic patientsR C Sachdeo, S K Sachdeo, R H Levy, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Biochemical Pharmacology|July 29, 1999
Cytotoxicity induced by the combination of valproic acid and tumor necrosis factor-alpha: implication for valproic acid-associated hepatotoxicity syndromeC P Yao, G G Mather, J R Stephens, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|May 1, 1991
Effects of subchronic exposure of rats to 2-methoxyethanol or 2-butoxyethanol: thymic atrophy and immunotoxicityJ H Exon, G G Mather, J L Bussiere, et al.
Reproductive Toxicology (Elmsford, N.Y.)|April 23, 1999
Effect of stiripentol dose on phenytoin-induced teratogenesis in a mouse modelR H Finnell, G D Bennett, G G Mather, et al.
Clinical Pharmacokinetics|October 7, 1997
Pharmacokinetic interactions with felbamate. In vitro-in vivo correlationP Glue, C R Banfield, J L Perhach, et al.
Chirality|February 26, 2000
Nefopam enantiomers: preclinical pharmacology/toxicology and pharmacokinetic characteristics in healthy subjects after intravenous administrationG G Mather, R Labroo, M E Le Guern, et al.
Journal of Clinical Pharmacology|March 20, 1998
Lack of effect of azelastine and ketoconazole coadministration on electrocardiographic parameters in healthy volunteersJ Morganroth, W H Lyness, J L Perhach, et al.
Clinical Pharmacology and Therapeutics|December 9, 1997
Influence of stiripentol on cytochrome P450-mediated metabolic pathways in humans: in vitro and in vivo comparison and calculation of in vivo inhibition constantsA Tran, E Rey, G Pons, et al.
Epilepsia|July 10, 2002
Topiramate and phenytoin pharmacokinetics during repetitive monotherapy and combination therapy to epileptic patientsR C Sachdeo, S K Sachdeo, R H Levy, et al.
Pageof 2